Logo image of BA

BOEING CO/THE (BA) Stock Fundamental Analysis

USA - NYSE:BA - US0970231058 - Common Stock

214 USD
-0.3 (-0.14%)
Last: 10/15/2025, 8:15:13 PM
214.6 USD
+0.6 (+0.28%)
Pre-Market: 10/16/2025, 8:41:40 AM
Fundamental Rating

1

BA gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 69 industry peers in the Aerospace & Defense industry. BA may be in some trouble as it scores bad on both profitability and health. BA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year BA has reported negative net income.
BA had a negative operating cash flow in the past year.
In the past 5 years BA always reported negative net income.
In multiple years BA reported negative operating cash flow during the last 5 years.
BA Yearly Net Income VS EBIT VS OCF VS FCFBA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B

1.2 Ratios

With a Return On Assets value of -7.04%, BA is not doing good in the industry: 69.57% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.04%
ROE N/A
ROIC N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BA Yearly ROA, ROE, ROICBA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K 2K 3K

1.3 Margins

BA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BA Yearly Profit, Operating, Gross MarginsBA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

More info and screens

1

2. Health

2.1 Basic Checks

BA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BA has been increased compared to 1 year ago.
The number of shares outstanding for BA has been increased compared to 5 years ago.
BA has a better debt/assets ratio than last year.
BA Yearly Shares OutstandingBA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
BA Yearly Total Debt VS Total AssetsBA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

Based on the Altman-Z score of 1.22, we must say that BA is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BA (1.22) is worse than 79.71% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1.22
ROIC/WACCN/A
WACC9.27%
BA Yearly LT Debt VS Equity VS FCFBA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

BA has a Current Ratio of 1.23. This is a normal value and indicates that BA is financially healthy and should not expect problems in meeting its short term obligations.
BA has a Current ratio of 1.23. This is in the lower half of the industry: BA underperforms 75.36% of its industry peers.
BA has a Quick Ratio of 1.23. This is a bad value and indicates that BA is not financially healthy enough and could expect problems in meeting its short term obligations.
BA's Quick ratio of 0.38 is on the low side compared to the rest of the industry. BA is outperformed by 91.30% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 0.38
BA Yearly Current Assets VS Current LiabilitesBA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B 100B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for BA have decreased strongly by -132.86% in the last year.
The Revenue has been growing slightly by 2.41% in the past year.
The Revenue has been decreasing by -4.74% on average over the past years.
EPS 1Y (TTM)-132.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.24%
Revenue 1Y (TTM)2.41%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%34.88%

3.2 Future

The Earnings Per Share is expected to grow by 21.08% on average over the next years. This is a very strong growth
Based on estimates for the next years, BA will show a quite strong growth in Revenue. The Revenue will grow by 14.49% on average per year.
EPS Next Y88.01%
EPS Next 2Y47.05%
EPS Next 3Y32.54%
EPS Next 5Y21.08%
Revenue Next Year27.91%
Revenue Next 2Y20.12%
Revenue Next 3Y17.4%
Revenue Next 5Y14.49%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BA Yearly Revenue VS EstimatesBA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50B 100B 150B
BA Yearly EPS VS EstimatesBA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 -10 -20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BA. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 64.73, the valuation of BA can be described as expensive.
BA's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 23.04. BA is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 64.73
BA Price Earnings VS Forward Price EarningsBA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BA Per share dataBA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BA's earnings are expected to grow with 32.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.05%
EPS Next 3Y32.54%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOEING CO/THE

NYSE:BA (10/15/2025, 8:15:13 PM)

Premarket: 214.6 +0.6 (+0.28%)

214

-0.3 (-0.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners74.41%
Inst Owner Change-0.02%
Ins Owners0.03%
Ins Owner Change-1.3%
Market Cap161.82B
Analysts84.12
Price Target264.25 (23.48%)
Short Float %2.19%
Short Ratio2.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)40.93%
Min EPS beat(2)18.67%
Max EPS beat(2)63.2%
EPS beat(4)3
Avg EPS beat(4)-1.39%
Min EPS beat(4)-91.07%
Max EPS beat(4)63.2%
EPS beat(8)5
Avg EPS beat(8)3%
EPS beat(12)6
Avg EPS beat(12)-778.57%
EPS beat(16)6
Avg EPS beat(16)-766.17%
Revenue beat(2)1
Avg Revenue beat(2)-0.79%
Min Revenue beat(2)-2.69%
Max Revenue beat(2)1.11%
Revenue beat(4)1
Avg Revenue beat(4)-3.27%
Min Revenue beat(4)-8.71%
Max Revenue beat(4)1.11%
Revenue beat(8)2
Avg Revenue beat(8)-2.51%
Revenue beat(12)3
Avg Revenue beat(12)-2.89%
Revenue beat(16)3
Avg Revenue beat(16)-5.01%
PT rev (1m)0.91%
PT rev (3m)15.6%
EPS NQ rev (1m)-165.61%
EPS NQ rev (3m)-263.86%
EPS NY rev (1m)-27.3%
EPS NY rev (3m)-49.08%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.71%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)3.17%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 64.73
P/S 2.15
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-18.07
EYN/A
EPS(NY)3.31
Fwd EY1.54%
FCF(TTM)-11.3
FCFYN/A
OCF(TTM)-8.18
OCFYN/A
SpS99.62
BVpS-4.36
TBVpS-16.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.27%
ROA(5y)-4.73%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.49
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 125.6%
Cap/Sales 3.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 0.38
Altman-Z 1.22
F-Score3
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)90.02%
Cap/Depr(5y)74.76%
Cap/Sales(3y)2.43%
Cap/Sales(5y)2.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-132.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%57.24%
EPS Next Y88.01%
EPS Next 2Y47.05%
EPS Next 3Y32.54%
EPS Next 5Y21.08%
Revenue 1Y (TTM)2.41%
Revenue growth 3Y2.21%
Revenue growth 5Y-4.74%
Sales Q2Q%34.88%
Revenue Next Year27.91%
Revenue Next 2Y20.12%
Revenue Next 3Y17.4%
Revenue Next 5Y14.49%
EBIT growth 1Y-418.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year140.25%
EBIT Next 3Y49.38%
EBIT Next 5Y32.37%
FCF growth 1Y-209.12%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-167.19%
OCF growth 3YN/A
OCF growth 5YN/A